Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China. Issue 2 (5th December 2021)
- Record Type:
- Journal Article
- Title:
- Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China. Issue 2 (5th December 2021)
- Main Title:
- Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China
- Authors:
- Liu, Cui‐Mei
Hua, Zhen‐Dong
Jia, Wei
Li, Tao - Abstract:
- Abstract: To curb the manufacturing, trafficking, and abuse of synthetic cannabinoids, China implemented a class‐wide regulation on synthetic cannabinoids in July 2021. Recently, three different types of synthetic cannabinoid analogs that were not covered by the generic definitions were detected in seized powdered and e‐liquid materials. These derivatives included 2‐(2‐(1‐(4‐fluorobenzyl)‐1 H ‐indol‐3‐yl)acetamido)‐3, 3‐dimethylbutanamide (AD‐18), N ′‐(1‐(5‐fluoropentyl)‐2‐oxoindolin‐3‐ylidene)benzohydrazide (5F‐MDA‐19), and N ′‐(2‐oxo‐1‐pentylindolin‐3‐ylidene)benzohydrazide (pentyl MDA‐19). Identification was based on ultra‐high‐performance liquid chromatography–quadrupole time‐of‐flight–mass spectrometry (UHPLC–QTOF–MS), gas chromatography–mass spectrometry (GC–MS), nuclear magnetic resonance spectroscopy (NMR), and Fourier transform infrared spectroscopy (FT‐IR). AD‐18 is a methylene analog of ADB‐FUBICA. No chemical or pharmacological data about AD‐18 and 5F‐MDA‐19 have appeared until now, making this the first report on these two compounds. Pentyl MDA‐19 has previously been reported to have high affinity for cannabinoid CB1 and CB2 receptors, but this is the first report of its presence in the recreational drug market. Moreover, the collision‐induced dissociation (CID) and electron ionization (EI) characteristic fragmentation routes of AD‐18 and the other two MDA‐19 derivatives were also discussed to facilitate forensic laboratories in their identification of otherAbstract: To curb the manufacturing, trafficking, and abuse of synthetic cannabinoids, China implemented a class‐wide regulation on synthetic cannabinoids in July 2021. Recently, three different types of synthetic cannabinoid analogs that were not covered by the generic definitions were detected in seized powdered and e‐liquid materials. These derivatives included 2‐(2‐(1‐(4‐fluorobenzyl)‐1 H ‐indol‐3‐yl)acetamido)‐3, 3‐dimethylbutanamide (AD‐18), N ′‐(1‐(5‐fluoropentyl)‐2‐oxoindolin‐3‐ylidene)benzohydrazide (5F‐MDA‐19), and N ′‐(2‐oxo‐1‐pentylindolin‐3‐ylidene)benzohydrazide (pentyl MDA‐19). Identification was based on ultra‐high‐performance liquid chromatography–quadrupole time‐of‐flight–mass spectrometry (UHPLC–QTOF–MS), gas chromatography–mass spectrometry (GC–MS), nuclear magnetic resonance spectroscopy (NMR), and Fourier transform infrared spectroscopy (FT‐IR). AD‐18 is a methylene analog of ADB‐FUBICA. No chemical or pharmacological data about AD‐18 and 5F‐MDA‐19 have appeared until now, making this the first report on these two compounds. Pentyl MDA‐19 has previously been reported to have high affinity for cannabinoid CB1 and CB2 receptors, but this is the first report of its presence in the recreational drug market. Moreover, the collision‐induced dissociation (CID) and electron ionization (EI) characteristic fragmentation routes of AD‐18 and the other two MDA‐19 derivatives were also discussed to facilitate forensic laboratories in their identification of other substances with a similar structure in their case work. Abstract : Three synthetic cannabinoids AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 were identified by UHPLC–QTOF–MS, GC–MS, NMR, and FT‐IR. … (more)
- Is Part Of:
- Drug testing and analysis. Volume 14:Issue 2(2022)
- Journal:
- Drug testing and analysis
- Issue:
- Volume 14:Issue 2(2022)
- Issue Display:
- Volume 14, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 14
- Issue:
- 2
- Issue Sort Value:
- 2022-0014-0002-0000
- Page Start:
- 307
- Page End:
- 316
- Publication Date:
- 2021-12-05
- Subjects:
- 5F‐MDA‐19 -- AD‐18 -- new psychoactive substances (NPS) -- pentyl MDA‐19 -- synthetic cannabinoid
Drugs -- Analysis -- Periodicals
Drug testing -- Periodicals
Chemistry, Forensic -- Periodicals
615.1901 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=110501 ↗
http://www3.interscience.wiley.com/journal/121408477/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/dta.3185 ↗
- Languages:
- English
- ISSNs:
- 1942-7603
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.424000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 27037.xml